The international provision of pharmaceuticals: a comparison of two alternative argumentative strategies for global ethics
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Global Ethics 7 (1):73 - 89 (2011)
Millions of people in the developing world lack access to curative drugs. Pogge identifies the cause of this problem as a lack of redistribution across borders. In contrast, this article shows that institutional shortcomings within developing countries are the main issue. These different explanations are the result of diverging analytic approaches to ethics: a cosmopolitan approach versus an ordonomic approach. This article compares both approaches with regard to how they conceptualize and propose to solve the problem of providing life-saving pharmaceuticals to the poor in developing countries
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Thomas W. Pogge (2005). Human Rights and Global Health: A Research Program. Metaphilosophy 36 (1‐2):182-209.
James M. Buchanan (1975). The Limits of Liberty: Between Anarchy and Leviathan. University of Chicago Press.
Thomas Pogge (2001). Priorities of Global Justice. Metaphilosophy 32 (1-2):6-24.
Thomas Pogge (2009). The Health Impact Fund and its Justification by Appeal to Human Rights. Journal of Social Philosophy 40 (4):542-569.
Christoph Luetge (2005). Economic Ethics, Business Ethics and the Idea of Mutual Advantages. Business Ethics 14 (2):108–118.
Citations of this work BETA
Roland Bardy, Stephen Drew & Tumenta F. Kennedy (2012). Foreign Investment and Ethics: How to Contribute to Social Responsibility by Doing Business in Less-Developed Countries. [REVIEW] Journal of Business Ethics 106 (3):267-282.
Similar books and articles
Why the international market for pharmaceuticals fails & What to Do About It : A. Comparison of Two Alternative Approaches to Global Ethics (2008). Reflecting the Impact of Ethical Theory : Contractarianism, Ethics, and Economics. Christoph Luetge / Civilising the Barbarians? : On the Apparent Necessity of Moral Surpluses; Soeren Buttkereit and Ingo Pies / Social Dilemmas and the Social Contract; Peter Koslowski / Ethical Economy as the Economy of Ethics and as the Ethics of the Market Economy; Ingo Pies and Stefan Hielscher. In Jesús Conill Sancho, Christoph Luetge & Tatjana Schó̈nwälder-Kuntze (eds.), Corporate Citizenship, Contractarianism and Ethical Theory: On Philosophical Foundations of Business Ethics. Ashgate Pub. Company
Nicole Hassoun (2012). Global Health Impact: A Basis for Labeling and Licensing Campaigns? Developing World Bioethics 12 (3):121-134.
Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander (2012). Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability Under the Right to Health. Journal of Law, Medicine & Ethics 40 (2):234-250.
Paul Kapelus (2002). Mining, Corporate Social Responsibility and the "Community": The Case of Rio Tinto, Richards Bay Minerals and the Mbonambi. [REVIEW] Journal of Business Ethics 39 (3):275 - 296.
Christian Barry & Gerhard Øverland (2012). The Feasible Alternatives Thesis: Kicking Away the Livelihoods of the Global Poor. Politics, Philosophy and Economics 11 (1):97-119.
Gerald F. Cavanagh (2004). Global Business Ethics. Business Ethics Quarterly 14 (4):625-642.
Sirine Shebaya, Andrea Sutherland, Orin Levine & Ruth Faden (2010). Alternatives to National Average Income Data as Eligibility Criteria for International Subsidies: A Social Justice Perspective. Developing World Bioethics 10 (3):141-149.
Albert Mosley (2008). Global Pharmaceuticals: Ethics, Markets, Practices – Edited by Adriana Petryna, Andrew Lakoff and Arthur Kleinman. Developing World Bioethics 8 (2):162-164.
Mathias Risse (2005). Do We Owe the Global Poor Assistance or Rectification? Ethics and International Affairs 19 (1):9–18.
Sagar Sanyal (2009). Political Equality and Global Poverty: An Alternative Egalitarian Approach to Distributive Justice. Dissertation, University of Canterbury
Meri Koivusalo (2010). Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies. Ethics and International Affairs 24 (4):395-414.
Jillian Clare Cohen & Patricia Illingworth (2003). The Dilemma of Intellectual Property Rights for Pharmaceuticals: The Tension Between Ensuring Access of the Poor to Medicines and Committing to International Agreements. Developing World Bioethics 3 (1):27–48.
Laura Calkins (2010). Detained and Drugged: A Brief Overview of the Use of Pharmaceuticals for the Interrogation of Suspects, Prisoners, Patients, and Pows in the Us. Bioethics 24 (1):27-34.
Juha Räikkä (2006). Pogge on Global Poverty. Journal of Global Ethics 2 (1):111 – 118.
Roberta Berry (2011). A Small Bioethical World? HEC Forum 23 (1):1-14.
Added to index2011-04-17
Total downloads15 ( #171,927 of 1,725,632 )
Recent downloads (6 months)1 ( #349,437 of 1,725,632 )
How can I increase my downloads?